CoChat
Sign Up
Cited by 26

The DOI matches its Crossref record.

Identification of Metabolites, Clinical Chemistry Markers and Transcripts Associated with Hepatotoxicity

Buness, Andreas, Roth, Adrian, Herrmann, Annika, Schmitz, Oliver, Kamp, Hennicke, Busch, Kristina, Suter, Laura·2014·PLoS ONE
DOI 10.1371/journal.pone.0097249PMC PMC4023975
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0097249

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 27

  1. VJ Navarro, 2006, Drug-related hepatotoxicity, N Engl J Med, 354, 731, 10.1056/NEJMra052270 · DOI · Paper page
  2. FM Goodsaid, 2009, Novel biomarkers of acute kidney toxicity, Clin Pharmacol Ther, 86, 490, 10.1038/clpt.2009.149 · DOI
  3. F Dieterle, 2010, Urinary clusterin, cystatin c, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury, Nat Biotechnol, 28, 463, 10.1038/nbt.1622 · DOI
  4. VS Vaidya, 2010, Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies, Nat Biotechnol, 28, 478, 10.1038/nbt.1623 · DOI
  5. KJ Boudonck, 2009, Discovery of metabolomics biomarkers for early detection of nephrotoxicity, Toxicol Pathol, 37, 280, 10.1177/0192623309332992 · DOI
  6. V Strauss, 2009, Influence of strain and sex on the metabolic profile of rats in repeated dose toxicological studies, Toxicol Lett, 191, 88, 10.1016/j.toxlet.2009.08.004 · DOI
  7. DG Robertson, 2011, Metabolomics in toxicology: preclinical and clinical applications, Toxicol Sci, 120, S146, 10.1093/toxsci/kfq358 · DOI
  8. A Zhang, 2012, Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity, Pharmazie, 67, 99
  9. H Kamp, 2012, Application of in vivo metabolomics to preclinical/toxicological studies: case study on phenytoin-induced systemic toxicity, Bioanalysis, 4, 2291, 10.4155/bio.12.214 · DOI
  10. U Roessner, 2000, Technical advance: simultaneous analysis of metabolites in potato tuber by gas chromatography-mass spectrometry, Plant J, 23, 131, 10.1046/j.1365-313x.2000.00774.x · DOI
  11. J Huang, 2010, Genomic indicators in the blood predict drug-induced liver injury, Pharmacogenomics J, 10, 267, 10.1038/tpj.2010.33 · DOI
  12. J Ozer, 2008, The current state of serum biomarkers of hepatotoxicity, Toxicology, 245, 194, 10.1016/j.tox.2007.11.021 · DOI
  13. D Ennulat, 2010, Diagnostic performance of traditional hepatobiliary biomarkers of drug-induced liver injury in the rat, Toxicol Sci, 116, 397, 10.1093/toxsci/kfq144 · DOI
  14. R Temple, 2006, Hy’s law: predicting serious hepatotoxicity, Pharmacoepidemiol Drug Saf, 15, 241, 10.1002/pds.1211 · DOI
  15. SL Friedman, 1996, Hepatic stellate cells, Prog Liver Dis, 14, 101
  16. PD Berk, 1978, Hyperbilirubinemia and cholestasis, Am J Med, 64, 311, 10.1016/0002-9343(78)90061-X · DOI
  17. B van Ravenzwaay, 2007, The use of metabolomics for the discovery of new biomarkers of effect, Toxicol Lett, 172, 21, 10.1016/j.toxlet.2007.05.021 · DOI
  18. Ravenzwaay B, Cunha GC, Fabian E, Herold M, Kamp H, <etal>et al</etal>.. (2010) The Use of Metabolomics in Cancer Research. Springer-Verlag, 141–166 pp. DOI: 10.1007/978–90–481–2675–0_8. · DOI
  19. ME Bollard, 2001, Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)h nmr spectroscopy of urine and pattern recognition, Anal Biochem, 295, 194, 10.1006/abio.2001.5211 · DOI
  20. J Azmi, 2005, Chemometric analysis of biofluids following toxicant induced hepatotoxicity: a metabonomic approach to distinguish the effects of 1-naphthylisothiocyanate from its products, Xenobiotica, 35, 839, 10.1080/00498250500297940 · DOI
  21. Sun J, Ando Y, Ahlbory-Dieker D, Schnackenberg L, Yang X, <etal>et al</etal>.. (2013) Systems biology investigation to discover metabolic biomarkers of acetaminophen-induced hepatic injury using integrated transcriptomics and metabolomics. Journal of Molecular Biomarkers & Diagnosis S1. Available: http://omicsonline.org/systems-biology-investigation-to-discover-metabolic-biomarkers-of-acetaminophen-induced-hepatic-injury-using-integrated-transcriptomics-and-metabolomics-2155-9929.S1-002.pdf. Accessed 28 April 2014.
  22. DM Mosser, 2008, Exploring the full spectrum of macrophage activation, Nat Rev Immunol, 8, 958, 10.1038/nri2448 · DOI · Paper page
  23. MT Pritchard, 2005, Ethanol-induced liver injury: potential roles for egr-1, Alcohol Clin Exp Res, 29, 146S, 10.1097/01.alc.0000189286.81943.51 · DOI
  24. JT DeLigio, 2009, Early growth response 1 (egr1): a gene with as many names as biological functions, Cancer Biol Ther, 8, 1889, 10.4161/cbt.8.20.9804 · DOI
  25. Y Xu, 2010, Advanced glycation end product (age)-receptor for age (rage) signaling and up-regulation of egr-1 in hypoxic macrophages, J Biol Chem, 285, 23233, 10.1074/jbc.M110.117457 · DOI
  26. JI Leu, 2003, Impaired hepatocyte dna synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in c/ebp beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation, Mol Cell Biol, 23, 1251, 10.1128/MCB.23.4.1251-1259.2003 · DOI
  27. JIJ Leu, 2007, Hepatic igfbp1 is a prosurvival factor that binds to bak, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria, Genes Dev, 21, 3095, 10.1101/gad.1567107 · DOI

Cited by

Sorted by citations

Metadata

Authors
Buness, A., Roth, A., Herrmann, A., Schmitz, O., Kamp, H., Busch, K., & Suter, L.
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2014-05-16
Volume
9
Issue
5
Pages
e97249
ISSN
1932-6203
DOI
10.1371/journal.pone.0097249
PMC
PMC4023975
Cited by
26
References
0
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review